pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
divarasib · news · pharmadog
← back to divarasib
News mentioning divarasib
12
stories
23d
STAT+: RFK Jr. goes for broke in Iowa
stat
23d
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
stat
23d
A possible treatment for brain-eating amoebas, found in the sea
stat
23d
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
stat
23d
Opinion: Cancer vaccines are finally here. How do we get them to patients?
stat
23d
From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data drama
fiercebiotech
24d
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
stat
24d
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
biopharma dive
24d
STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
stat
26d
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
fiercebiotech
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints